ArticleCureus2026

Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility.

Rubens C Siqueira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.